会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • A METHOD AND APPARATUS FOR PROVIDING A DECORATIVE SURFACE
    • 一种提供装饰性表面的方法和装置
    • WO2010080338A2
    • 2010-07-15
    • PCT/US2009067612
    • 2009-12-11
    • MOTOROLA INCDEAN KENNETH AJOHNSON MICHAEL RHEIKENFELD JASON C
    • DEAN KENNETH AJOHNSON MICHAEL RHEIKENFELD JASON C
    • H05K5/02B29C45/14
    • H04M1/0283G02B26/004
    • A decorative housing (11) for a mobile device (10) includes a first faceted cell (12) having a first angled electro-optic element (14) disposed therein. A second faceted cell (16) is adjacent the first cell (12) and has second angled electro-optic elements (18). A liquid (20) is in fluid communication with each faceted cell (12, 16) and moveable to a first position (22) in response to a first electric field (24) applied to one of the first and second electro-optic elements (14, 18) and moveable to a second position (26) in response to a second electric field (28) applied to the other of the first and second electro-optic elements (14, 18). An electronic modulator (30) is coupled to the first electro-optic element (14) and the second electro-optic element (18) to electronically modulate between the first electric field (24) and the second electric field (28).
    • 用于移动设备(10)的装饰外壳(11)包括具有设置在其中的第一倾斜电光元件(14)的第一刻面单元(12)。 第二刻面单元(16)与第一单元(12)相邻并且具有第二成角度的电光元件(18)。 响应于施加到第一和第二电光元件之一的第一电场(24),液体(20)与每个刻面单元(12,16)流体连通并且可移动到第一位置(22) 响应于施加到第一和第二电光元件(14,18)中的另一个的第二电场(28),可移动到第二位置(26)。 电子调制器(30)耦合到第一电光元件(14)和第二电光元件(18)以在第一电场(24)和第二电场(28)之间电子调制。
    • 8. 发明申请
    • LIGHT EMISSIVE DISPLAY BASED ON LIGHTWAVE COUPLING
    • 基于轻型联轴器的轻型电动显示器
    • WO2005057261A3
    • 2005-10-06
    • PCT/US2004040819
    • 2004-12-07
    • UNIV CINCINNATISTECKL ANDREW JHEIKENFELD JASON C
    • STECKL ANDREW JHEIKENFELD JASON C
    • G02B6/35G02B26/02G09F9/37
    • G02B26/02Y10S385/90
    • A light emissive display having a specular waveguide (12, 12a-c, 80, 184) that propagates short wavelength light from a light source (34, 185) and devices (10, 10a-g, 110, 120, 140, 154, 170, 180) with photoluminescent features (24, 136, 141, 142, 166, 182) adjacent to the waveguide (12, 12a-c, 80, 184) that fluoresce, for example, in visible red, green, blue, and mixed colors when selectively coupled with the short wavelength light. The devices (10, 10a-g, 110, 120, 140, 154, 170, 180) emit light primarily and, therefore, efficiently in the direction of an observer only. This light emissive display may be utilized as a planar light source, as patterned information signage, or as a re-configurable information display containing intensity modulated pixels. The light emissive display may be enhanced optically such that only a small portion of ambient light is reflected from the display while preserving the majority of emitted display luminance.
    • 一种具有从光源(34,185)和装置(10,10a-g,110,120,140,​​154)传播短波长光的镜面波导(12,12a-c,80,184)的光发射显示器, 具有邻近波导(12,12a-c,80,184)的光致发光特征(24,136,141,142,166,182),其以例如可见红,绿,蓝和 选择性地与短波长光耦合时的混合颜色。 装置(10,10a-g,110,120,140,​​154,170,180)主要发射光,因此仅在观察者的方向上有效地发光。 该光发射显示器可以用作平面光源,作为图案化信息标牌,或作为包含强度调制像素的可重构信息显示。 光发射显示器可以光学增强,使得只有一小部分环境光从显示器反射,同时保持大部分发射的显示亮度。
    • 10. 发明申请
    • SWEAT MONITORING AND CONTROL OF DRUG DELIVERY
    • 药物传递的SWEAT监测和控制
    • WO2015184084A2
    • 2015-12-03
    • PCT/US2015032866
    • 2015-05-28
    • UNIV CINCINNATI
    • HEIKENFELD JASON C
    • A61B5/053A61B5/00
    • A61B5/14517A61B5/0531A61B5/14546A61B5/4266A61B5/4839A61B5/6804A61B5/6831A61M37/0015A61M2037/0007A61M2037/0023A61M2230/005A61N1/0412A61N1/0448A61N1/327
    • The concentration of an administered compound, such as a drug (D), in an organ or a bodily fluid, such as blood, is determined directly through detecting the drug (D) or its metabolites (DM) in sweat. The concentration may be determined indirectly by administering the drug (D) together with one or more tracer compounds (T, T2) or metabolites thereof (TM, T2M) or by detecting concentrations and trends of other analytes present in the body that react to the presence of the drug (D). By determining tracer concentration in sweat, the concentration of the drug (D) in blood or an organ can be determined. The tracer (T, T2) is a compound selected for ease of detection in sweat, known metabolic and solubility profiles that correspond to those of the drug (D), and safety of use. A smart transdermal delivery patch (300) is used to administer a dosage of drug to a wearer in coordination with at least one sweat sensor (324) reading conveying information about the wearer.
    • 通过检测出汗液中的药物(D)或其代谢物(DM),可以直接测定给药化合物(例如药物(D))在器官或体液如血液中的浓度。 可以通过将药物(D)与一种或多种示踪剂化合物(T,T2)或其代谢物(TM,T2M)一起施用或通过检测存在于身体中的其它分析物的浓度和趋势来间接测定浓度 药物的存在(D)。 通过测定汗液中的示踪剂浓度,可以确定血液或器官中药物(D)的浓度。 示踪剂(T,T2)是选择用于在汗液中易于检测的化合物,已知的与药物(D)的代谢和溶解度特征对应的代谢和溶解度分布以及使用的安全性。 使用智能透皮递送贴片(300),以与至少一个读取关于穿着者的传递信息的汗液传感器(324)协调地向使用者施用一定剂量的药物。